Geode Capital Management’s Arbutus Biopharma ABUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
3,637,021
+95,876
| +3% | +$296K | ﹤0.01% | 2286 |
|
|
2025
Q1 | $12.4M | Buy |
3,541,145
+59,009
| +2% | +$206K | ﹤0.01% | 2159 |
|
|
2024
Q4 | $11.4M | Buy |
3,482,136
+33,536
| +1% | +$110K | ﹤0.01% | 2291 |
|
|
2024
Q3 | $13.3M | Buy |
3,448,600
+135,442
| +4% | +$522K | ﹤0.01% | 2207 |
|
|
2024
Q2 | $10.2M | Buy |
3,313,158
+354,271
| +12% | +$1.09M | ﹤0.01% | 2312 |
|
|
2024
Q1 | $7.63M | Buy |
2,958,887
+141,192
| +5% | +$364K | ﹤0.01% | 2483 |
|
|
2023
Q4 | $7.04M | Buy |
2,817,695
+120,611
| +4% | +$302K | ﹤0.01% | 2523 |
|
|
2023
Q3 | $5.48M | Buy |
2,697,084
+98,958
| +4% | +$201K | ﹤0.01% | 2589 |
|
|
2023
Q2 | $5.98M | Buy |
2,598,126
+310,213
| +14% | +$713K | ﹤0.01% | 2594 |
|
|
2023
Q1 | $6.93M | Buy |
2,287,913
+156,645
| +7% | +$475K | ﹤0.01% | 2478 |
|
|
2022
Q4 | $4.97M | Buy |
2,131,268
+121,428
| +6% | +$283K | ﹤0.01% | 2672 |
|
|
2022
Q3 | $3.84M | Buy |
2,009,840
+224,798
| +13% | +$429K | ﹤0.01% | 2808 |
|
|
2022
Q2 | $4.84M | Buy |
1,785,042
+55,064
| +3% | +$149K | ﹤0.01% | 2717 |
|
|
2022
Q1 | $5.16M | Buy |
1,729,978
+60,354
| +4% | +$180K | ﹤0.01% | 2782 |
|
|
2021
Q4 | $6.49M | Buy |
1,669,624
+129,193
| +8% | +$502K | ﹤0.01% | 2737 |
|
|
2021
Q3 | $6.61M | Buy |
1,540,431
+253,773
| +20% | +$1.09M | ﹤0.01% | 2750 |
|
|
2021
Q2 | $3.9M | Buy |
1,286,658
+752,076
| +141% | +$2.28M | ﹤0.01% | 3049 |
|
|
2021
Q1 | $1.78M | Buy |
534,582
+132,931
| +33% | +$443K | ﹤0.01% | 3305 |
|
|
2020
Q4 | $1.43M | Buy |
401,651
+21,274
| +6% | +$75.5K | ﹤0.01% | 3249 |
|
|
2020
Q3 | $1.19M | Buy |
380,377
+67,347
| +22% | +$211K | ﹤0.01% | 3140 |
|
|
2020
Q2 | $569K | Buy |
313,030
+204,634
| +189% | +$372K | ﹤0.01% | 3325 |
|
|
2020
Q1 | $109K | Sell |
108,396
-19,117
| -15% | -$19.2K | ﹤0.01% | 3738 |
|
|
2019
Q4 | $354K | Buy |
127,513
+52,387
| +70% | +$145K | ﹤0.01% | 3617 |
|
|
2019
Q3 | $114K | Sell |
75,126
-1,569
| -2% | -$2.38K | ﹤0.01% | 3918 |
|
|
2019
Q2 | $159K | Sell |
76,695
-186,295
| -71% | -$386K | ﹤0.01% | 3847 |
|
|
2019
Q1 | $941K | Buy |
262,990
+27,058
| +11% | +$96.8K | ﹤0.01% | 3183 |
|
|
2018
Q4 | $903K | Buy |
235,932
+51,127
| +28% | +$196K | ﹤0.01% | 3144 |
|
|
2018
Q3 | $1.75M | Buy |
184,805
+61,017
| +49% | +$576K | ﹤0.01% | 2961 |
|
|
2018
Q2 | $903K | Buy |
123,788
+109,520
| +768% | +$799K | ﹤0.01% | 3226 |
|
|
2018
Q1 | $71K | Hold |
14,268
| – | – | ﹤0.01% | 3904 |
|
|
2017
Q4 | $72K | Sell |
14,268
-12,847
| -47% | -$64.8K | ﹤0.01% | 3875 |
|
|
2017
Q3 | $168K | Hold |
27,115
| – | – | ﹤0.01% | 3705 |
|
|
2017
Q2 | $97K | Sell |
27,115
-378
| -1% | -$1.35K | ﹤0.01% | 3849 |
|
|
2017
Q1 | $89K | Buy |
27,493
+858
| +3% | +$2.78K | ﹤0.01% | 3846 |
|
|
2016
Q4 | $65K | Buy |
26,635
+572
| +2% | +$1.4K | ﹤0.01% | 3873 |
|
|
2016
Q3 | $89K | Buy |
26,063
+143
| +0.6% | +$488 | ﹤0.01% | 3829 |
|
|
2016
Q2 | $90K | Buy |
25,920
+5,717
| +28% | +$19.9K | ﹤0.01% | 3820 |
|
|
2016
Q1 | $83 | Sell |
20,203
-143
| -0.7% | -$1 | ﹤0.01% | 3878 |
|
|
2015
Q4 | $90K | Buy |
20,346
+286
| +1% | +$1.27K | ﹤0.01% | 3904 |
|
|
2015
Q3 | $122K | Buy |
20,060
+2,866
| +17% | +$17.4K | ﹤0.01% | 3837 |
|
|
2015
Q2 | $203K | Buy |
17,194
+5,007
| +41% | +$59.1K | ﹤0.01% | 3584 |
|
|
2015
Q1 | $212K | Buy |
+12,187
| New | +$212K | ﹤0.01% | 3558 |
|